Zufinib 250 mg Tablet
34,02$
26,54$
Zufinib 250 mg Tablet is an innovative treatment option designed for adults battling advanced non-small cell lung cancer (NSCLC) with genetic mutations in the EGFR gene, particularly in cases where the disease has metastasized. This targeted therapy works by inhibiting the growth of cancer cells, thereby slowing disease progression and improving patient outcomes. It is important to note that Zufinib is not recommended for pediatric patients due to insufficient data on its safety and effectiveness in children and adolescents. As with any medication, potential side effects may occur, making it crucial for patients to discuss their medical history with their healthcare provider before starting treatment. Regular monitoring during therapy is essential to manage any adverse reactions that may arise. Zufinib 250 mg Tablet represents a significant advancement in personalized cancer care, offering hope to those who have not previously undergone cancer treatment. For optimal results, adherence to the prescribed regimen and follow-up consultations with healthcare professionals are strongly advised.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Zufinib 250 mg tablet is primarily indicated for the treatment of non-small cell lung cancer (NSCLC). This type of lung cancer is characterized by the rapid growth of cancer cells in the lung tissue. By targeting specific pathways involved in cancer cell proliferation, Zufinib helps to slow down disease progression. It is typically used when patients have advanced or metastatic forms of this cancer.
• In addition to its role in treating NSCLC, Zufinib 250 mg tablet may be utilized in patients who have shown resistance to previous therapies. This makes it a valuable option for individuals whose cancer has not responded to standard treatments. The medicine works by inhibiting tumor growth signals, thereby offering a new avenue for management. Oncologists often consider Zufinib as part of a comprehensive treatment plan.
• Zufinib 250 mg tablet is also beneficial for patients experiencing specific genetic mutations associated with lung cancer. These mutations can drive the growth of tumors, and Zufinib is designed to target them effectively. By doing so, it can lead to improved outcomes for those affected. This targeted approach is crucial for personalized cancer therapy.
• The administration of Zufinib 250 mg tablet is generally guided by a healthcare professional based on the individual patient's condition. Regular monitoring is essential to assess the treatment's effectiveness and manage any necessary adjustments. This ensures that patients receive optimal care tailored to their specific cancer profile. Zufinib plays a significant role in modern oncology for managing non-small cell lung cancer.
Benefits
Zufinib Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Zufinib 250 Tablet may help to slow the progression of cancer.
Zufinib 250 mg may help reduce the severity of cancer-related symptoms, such as pain and fatigue, which can improve a patient's overall quality of life.
Zufinib Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
As with all medicines, Zufinib 250 mg Tablet may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.
Most Common Side Effects
• Tremor
• Hypertension
• Headache
• Increased Potassium levels in the blood
• Hypertension
• Gastrointestinal problems
• Abnormal Growth of Hair
Common Side Effects
• Liver Damage
• Seizures
• Infection
• Kidney Damage
• Memory Problems
• Vision Problems
• Sleeplessness
How To Use
It is recommended to consume Zufinib 250 mg Tablet with or without food. Be sure to swallow the tablet whole with a complete glass of water. Avoid crushing, chewing, or opening the tablet. In case you forget to take a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and adhere to your regular dosing schedule. Remember not to take two doses simultaneously to compensate for a missed dose.
Safety Advice
• Alcohol: The use of alcohol is generally not recommended while taking Zufinib 250 mg Tablet as it may increase the risk of liver damage. It is advisable to either abstain from alcohol or limit your alcohol intake while taking any medication.
• Kidney: Zufinib 250 mg Tablet is considered safe for patients with mild to moderate kidney disease and no dose adjustment of Zufinib 250 mg is required. However, people with severe kidney disease are advised not to take Zufinib 250 Tablet Tablet. To ensure the safety and effectiveness of your treatment, it is important to have an open discussion with your doctor about all your medical conditions and medications.
• Breastfeeding: It is not advisable to breast-feed while taking Zufinib 250 Tablet as this may cause harm to the baby. Zufinib 250 mg Tablet can pass into breast milk and cause adverse effects. If you are currently breastfeeding and using Zufinib Tablet, it is important to discuss with your doctor the potential risks and benefits of continuing to breastfeed. Your doctor will help you make the decision that is best for you and your baby.
• Liver: Zufinib 250 mg Tablet is considered safe for patients with mild to moderate liver disease, and there is no need to adjust the dose of Zufinib Tablet. However, people with severe liver disease should not use Zufinib 250 mg Tablet. It is important to have an open discussion with your doctor about your medical conditions and medications to ensure that the treatment plan is appropriate for you.
• Pregnancy: Zufinib 250 mg Tablet may be unsafe during pregnancy as animal studies suggest that it may harm the developing fetus. However, if you are pregnant or planning to get pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Zufinib 250 mg Tablet while pregnant. Your doctor will be able to help you make the decision that is best for you and for the health of your baby.
• Driving: Zufinib 250 mg Tablet may cause dizziness, drowsiness, and problems with concentration and coordination, which may impair your ability to drive a vehicle safely. It is important that you follow your doctor's instructions and take the necessary measures, such as avoiding driving or operating heavy machinery, if you experience any of these side effects caused by Zufinib Tablet.